--2025/Q1-- / 375.000K--
--2024/Q4-- / 301.590K--
--2024/Q30.000 / 709.320K--
--2024/Q21.143M / 841.780K--
--2024/Q1742.000K / 1.457M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
HOWL Werewolf Therapeutics
- 1.590
- +0.020+1.27%
Close Dec 20 16:00 ET
- 1.590
- 0.000-0.01%
Post 20:01 ET
70.86MMarket Cap-1.05P/E (TTM)
1.630High1.490Low606.11KVolume1.550Open1.570Pre Close954.60KTurnover2.38%Turnover RatioLossP/E (Static)44.56MShares8.19452wk High0.79P/B40.48MFloat Cap1.38052wk Low--Dividend TTM25.46MShs Float23.990Historical High--Div YieldTTM8.92%Amplitude1.380Historical Low1.574Avg Price1Lot Size
Werewolf Therapeutics Key Stats
Werewolf Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Werewolf Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data